MENU
CERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cerus (CERS) Ownership - Who owns Cerus?
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
342.62M
P/E Ratio
N/A
Total Cash
65.85M
Projected Growth
N/A
Total Debt
96M
Revenue
156.37M
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
7.28
Revenue/Share
0.87 USD as % of share price
Fundamentals
CERS
Capitalization
343M
P/E Ratio
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash
65.9M
Total Cash/Share
0.36
Total Debt
96M
Total Debt/Equity
7.28
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.87%
Revenue
156M
ROE
N/A
Book Value
52.6M
P/B Ratio
6.20
Cash Flow
N/A
Earnings
-0.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
181K
Current Ratio
2.14
Current Revenue Per Employee
167028.58
Dividends Per Share - Security
N/A
EBITDA
-26.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
55.51
Revenue To Assets
-18.03
Shares Held By Institutions
1.01B
Shares Outstanding - Current
181M
Total Liabilities
144M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-11.039
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of the INTERCEPT Blood System for platelets and plasma
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com